Hemispherx signs deal with Saudi Arabian drug company
Hemispherx BioPharma, in its first deal since the company’s new management, pledged to seek more partnerships, has entered into an agreement with a Saudi Arabian drug company.
The clinical trial, sales, marketing, distribution, and supply agreement was signed by Philadelphia-based Hemispherx and Scientific Products Pharmaceutical Co. Ltd. in Riyadh. The contract — which covers Saudi Arabia, United Arab Emirates, Kuwait, Oman, Qatar, and Bahrain — calls for Scientific Products to purchase certain…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news
More News: Bahrain Health | Clinical Trials | Contracts | Health | Health Management | Kuwait Health | Marketing | Middle East Health | Oman Health | Partnerships | Pharmaceuticals | Qatar Health